Lateral Flow POC Reader is a universal mobile analysis device for the qualitative and quantitative analysis of lateral flow assays, immunological rapid tests for point-of-care diagnostics. The tests can originate in multiple fields of application, such as cancer and heart disease diagnostics or drug screening.
Global Lateral Flow POC Reader key players include Abbott(Alere), QIAGEN, LRE Medical (Esterline), BD Company, Axxin, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45%.
In terms of product, Benchtop Readers is the largest segment, with a share over 65%.

Market Analysis and Insights: Global and China Lateral Flow POC Reader Market
This report focuses on global and China Lateral Flow POC Reader market.
In 2020, the global Lateral Flow POC Reader market size was US$ 575 million and it is expected to reach US$ 701.6 million by the end of 2027, with a CAGR of 2.9% during 2021-2027. In China the Lateral Flow POC Reader market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Lateral Flow POC Reader Scope and Market Size
Lateral Flow POC Reader market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lateral Flow POC Reader market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Lateral Flow POC Reader market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Digital/Mobile Readers
Benchtop Readers

Segment by Application
Pregnancy and Fertility Testing
Infectious Disease Testing
Cardiac Marker Testing
Cholesterol and Lipid Testing
Drugs-of-Abuse Testing
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbott (Alere)
QIAGEN
LRE Medical (Esterline)
BD Company
Axxin
Chembio Diagnostics (optricon)
Trinity Biotech
Detekt Biomedical
Quidel Corporation
Abingdon
Magnasense
Fio Corporation
NOW Diagnostic(Cellmic LLC)
Buhlmann Laboratories